These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 17687802)

  • 1. Common hepatitis B drug linked to HIV antiviral resistance.
    Future Microbiol; 2007 Apr; 2(2):104. PubMed ID: 17687802
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA, Bristol-Myers Squibb issue warning on hepatitis B drug.
    AIDS Read; 2007 Oct; 17(10):478-510. PubMed ID: 17987701
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA notifications. FDA revises Baraclude labeling for HIV patients.
    AIDS Alert; 2007 Sep; 22(9):103-4. PubMed ID: 18415955
    [No Abstract]   [Full Text] [Related]  

  • 4. Entecavir in HIV/HBV coinfection: possible HIV activity and resistance risk.
    AIDS Clin Care; 2007 Apr; 19(4):32. PubMed ID: 17695090
    [No Abstract]   [Full Text] [Related]  

  • 5. Very few hepatitis trials recruiting.
    AIDS Patient Care STDS; 1998 Apr; 12(4):319-20. PubMed ID: 11361965
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis B virus infection.
    Dienstag JL
    N Engl J Med; 2008 Oct; 359(14):1486-500. PubMed ID: 18832247
    [No Abstract]   [Full Text] [Related]  

  • 7. Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus.
    Benhamou Y; Tubiana R; Thibault V
    N Engl J Med; 2003 Jan; 348(2):177-8. PubMed ID: 12519935
    [No Abstract]   [Full Text] [Related]  

  • 8. Monitoring antiviral resistance in patients receiving nucleos(t)ide analog therapies for hepatitis B: which method should be used?
    Degertekin B; Lok AS
    J Hepatol; 2008 Jun; 48(6):892-4. PubMed ID: 18433924
    [No Abstract]   [Full Text] [Related]  

  • 9. Early hepatitis B virological rebound on entecavir through selection of lamivudine-associated mutations.
    Tong CY; Mullen JE; Wong T
    J Antimicrob Chemother; 2009 Oct; 64(4):875-7. PubMed ID: 19671587
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evolution of hepatitis B virus quasispecies during lamivudine-entecavir sequential therapy].
    Liu L; Tang YZ; Li JG; Zhou JJ; Wang XH; Wang YM
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jun; 18(6):423-7. PubMed ID: 20587311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New advances in the treatment of chronic hepatitis B: position of entecavir].
    Olaso V
    Rev Esp Quimioter; 2007 Sep; 20(3):259-60. PubMed ID: 18080023
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical characterization of peripheral neuropathy associated with entecavir in patients with HBV-induced cirrhosis].
    Zhang XH; Wu YK; Cao H; Wu ZB; Ke WM
    Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):707-8. PubMed ID: 23320271
    [No Abstract]   [Full Text] [Related]  

  • 13. Changing landscape of antiviral resistance management in chronic hepatitis B.
    Nguyen T; Locarnini S; Desmond P
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1314-7. PubMed ID: 18853991
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of anti-HIV activity of entecavir in an HIV patient coinfected with hepatitis B and delta viruses.
    Soriano V; Sheldon J; García-Gasco P; Vispo E
    AIDS; 2007 Oct; 21(16):2253-4. PubMed ID: 18090058
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis B virus-related membranous nephropathy treated with entecavir.
    Ikee R; Ishioka K; Oka M; Maesato K; Moriya H; Hidaka S; Ohtake T; Kobayashi S
    Nephrology (Carlton); 2010 Mar; 15(2):266. PubMed ID: 20470290
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial comment: HIV and HBV coinfection--a coming-of-age in treatment strategies.
    Ala A; Dieterich DT
    AIDS Read; 2004 Mar; 14(3):134-5. PubMed ID: 15068001
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV-hepatitis B virus coinfection: questions and answers.
    Valenti WM
    AIDS Read; 2005 May; 15(5):226-30. PubMed ID: 15900632
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of hepatitis B co-infected with HCV or HIV].
    Xie Q; Xiang XG
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jul; 18(7):491-4. PubMed ID: 20678436
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV-1/hepatitis B coinfection.
    Benhamou Y
    Expert Rev Anti Infect Ther; 2005 Apr; 3(2):229-39. PubMed ID: 15918780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in the treatment of acute hepatitis B].
    Mochida S; Fujiwara K
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():248-52. PubMed ID: 15453324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.